| Nov 4 |
Trending tickers: Berkshire Hathaway, Ryanair, Viking Therapeutics, Burberry
|
| Nov 4 |
BioNTech reports Q3 results, reconfirms FY guidance
|
| Nov 4 |
BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update
|
| Nov 1 |
Stocks to watch next week: Berkshire Hathaway, Super Micro, Novo Nordisk, Vistry and M&S
|
| Oct 31 |
BioNTech to Host Innovation Series R&D Day on November 14, 2024
|
| Oct 29 |
Pfizer CEO: The activist investors are 'too late'
|
| Oct 25 |
BioNTech to Report Q3 Earnings: Is a Beat in the Cards?
|
| Oct 23 |
A slow start for self-amplifying mRNA vaccines
|
| Oct 21 |
FDA Presses Clinical Hold Button For BioNTech's Partner Late-Stage Trial Of Investigational Lung Cancer Treatment
|
| Oct 21 |
BioNTech's Oncology Gamble: High Stakes, Big Potential
|
